Desogestrel versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation
暂无分享,去创建一个
[1] A. Lethaby,et al. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. , 2013, The Cochrane database of systematic reviews.
[2] F. Alameda,et al. Endometrial preparation with desogestrel before Essure hysteroscopic sterilization: preliminary study. , 2013, Journal of minimally invasive gynecology.
[3] David Moher,et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.
[4] R. Angioli,et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study. , 2010, Fertility and sterility.
[5] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.
[6] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[7] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[8] V. de Leo,et al. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study. , 2007, Fertility and sterility.
[9] J. Abbott. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy , 2006 .
[10] O. Triolo,et al. Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. , 2006, Fertility and sterility.
[11] P. Gambadauro,et al. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. , 2005, Acta obstetricia et gynecologica Scandinavica.
[12] D. Archer,et al. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone. , 2004, Contraception.
[13] R. Milne,et al. Evaluation of abnormal uterine bleeding , 2004 .
[14] G. Krikun,et al. Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression. , 2002, The American journal of pathology.
[15] L. Bradley. Complications in hysteroscopy: prevention, treatment and legal risk , 2002, Current opinion in obstetrics & gynecology.
[16] M. Gillmer,et al. Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium? , 2000, Human reproduction.
[17] D. Charnock-Jones,et al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. , 2000, Human reproduction.
[18] P. Vercellini,et al. Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: literature review. , 1998, Human reproduction.
[19] T. Römer. Benefit of GnRH Analogue Pretreatment for Hysteroscopic Surgery in Patients with Bleeding Disorders , 1998, Gynecologic and Obstetric Investigation.
[20] D. Battistutta,et al. The Effects of Danazol After Endometrial Resection: Results of a randomized, placebo‐controlled, double‐blind study , 1998, The Australian & New Zealand journal of obstetrics & gynaecology.
[21] J. Donnez,et al. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study. , 1997, Fertility and sterility.
[22] P. Vercellini,et al. Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial , 1996, British journal of obstetrics and gynaecology.
[23] K Wamsteker,et al. Transcervical Hysteroscopic Resection of Submucous Fibroids for Abnormal Uterine Bleeding: Results Regarding the Degree of Intramural Extension , 1993, Obstetrics and gynecology.
[24] Valle Rf,et al. Diagnostic and operative hysteroscopy. , 1974 .
[25] D. Moher,et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.
[26] Indications and options for endometrial ablation. , 2006, Fertility and sterility.
[27] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[28] D. Foth,et al. Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery. , 2000, Contributions to gynecology and obstetrics.
[29] A. Lethaby,et al. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding. , 2000, Cochrane Database of Systematic Reviews.
[30] L. Fedele,et al. Danazol versus a gonadotropin-releasing hormone agonist as preoperative preparation for hysteroscopic metroplasty. , 1996, Fertility and sterility.
[31] M. Baggish,et al. Diagnostic and Operative Hysteroscopy: A Text and Atlas , 1989 .
[32] H. Fox,et al. Biopsy pathology of the endometrium , 1989 .
[33] A. Ferenczy,et al. Endometrial hyperplasia and neoplasia. , 1982, Clinical obstetrics and gynecology.